The proteins could help at-risk children avoid disease development. It also points towards a new blood biomarker that could aid disease diagnosis and management.

Author Sharad Purohit said, "Individuals who have three of the known high-risk genes for type 1 diabetes but high serum levels of these four proteins were less likely to have disease, suggesting that these proteins may provide dominant levels of protection against type 1 diabetes even in a genetically high-risk group."
The research team claim that cytokines and chemokines could promote or inhibit inflammation and cytokines such as MIP-1beta can do both and the proper mix help keep inflammation in check. Dr. She said, "We were providing evidence that clinical trials with any of these four molecules may work and if we used them in combination, they may work even better."
The study was published in the Journal of Clinical Endocrinology and Metabolism.
Source-ANI